Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.
about
Tumor location and patient age predict biological signatures of high-grade gliomas.TGF-â1-induced miR-503 controls cell growth and apoptosis by targeting PDCD4 in glioblastoma cells.Correlation Between Ki-67 Index, World Health Organization Grade and Patient Survival in Glial Tumors With Astrocytic Differentiation.MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.One-Pot Aqueous Synthesis of Fluorescent Ag-In-Zn-S Quantum Dot/Polymer Bioconjugates for Multiplex Optical Bioimaging of Glioblastoma Cells.Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment.Current and emerging EGFR therapies for glioblastoma.Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications.Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: Case report and review of the literature.Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.Prognostic and clinicopathological value of melanoma-associated antigen D4 in patients with glioma.Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting.Periostin, a signal transduction intermediate in TGF-β-induced EMT in U-87MG human glioblastoma cells, and its inhibition by anthocyanidins.Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant AstrocytomasRadiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and PrognosisA Critical Overview of Targeted Therapies for Glioblastoma
P2860
Q38601045-A94DD24E-4095-49F9-968E-3A3F1B59D189Q41048323-5700383E-4BE7-4400-8112-52A930018BCEQ41524081-0BC7FEE6-BB5A-43FD-BC08-3FF639E26A14Q47107443-3D506026-4F57-4524-A356-60AA95A7F3AFQ47128307-54AEB22D-B0FD-4CB4-B674-57C48B2D56CFQ47273844-03B1249F-F269-4257-86AD-7A5CE2D285D5Q47875411-76713956-3EEA-4C2A-832E-F35C59DE3C08Q47878958-7738C5A7-D4AE-420B-A362-E152C100A1DFQ47942947-5101AA95-7EE4-4B11-8F52-F61239B2E892Q48350004-F32485C6-468E-49C2-8EF5-92D0BB9D30F5Q52590668-C6C244DA-6CAF-46C5-9D15-11A9340A1AE2Q52608456-5D3071B3-44DD-469C-858A-FBECBF882B48Q52646452-1025C1ED-36FD-41D2-B68B-0DF7530FF76AQ52655180-01E6D286-BC9C-4386-979F-1E3337F0A4AAQ52715769-0E1E791B-E81F-4948-938A-D3114FFCCA3AQ54965858-D8F354C6-2143-4959-B03B-F673445C1524Q54978821-C53421FA-0B01-45CF-B97A-FD08F40E563EQ57822861-F7820674-5CD7-4D52-BC5C-9A51F9C95BE2Q58099090-D7E4C5A7-9449-47B4-9C9D-037108C6DA4EQ58122179-72A90320-85D7-4B59-8FB4-284794573954
P2860
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Diagnostic and Therapeutic Bio ...... tatus and Future Perspectives.
@en
type
label
Diagnostic and Therapeutic Bio ...... tatus and Future Perspectives.
@en
prefLabel
Diagnostic and Therapeutic Bio ...... tatus and Future Perspectives.
@en
P2860
P50
P921
P356
P1476
Diagnostic and Therapeutic Bio ...... Status and Future Perspectives
@en
P2093
Gabriela Kramer-Marek
P2860
P304
P356
10.1155/2017/8013575
P407
P5008
P577
2017-02-20T00:00:00Z